Polyclonal antibody Diffistat-G
Alternative Names: Diffistat-GLatest Information Update: 23 Dec 1999
At a glance
- Originator GalaGen
- Class Polyclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Clostridium difficile infections
Most Recent Events
- 23 Dec 1999 Discontinued-II for Clostridium difficile infections in USA (PO)
- 25 Nov 1998 Suspended-II for Clostridium difficile infections in USA (PO)
- 22 Aug 1997 Phase-II clinical trials for Clostridium difficile infections in USA (PO)